Skip to main content
Ikonisys S.A. logo

Ikonisys S.A. — Investor Relations & Filings

Ticker · ALIKO ISIN · FR00140048X2 LEI · 9695000B742KPNDQ4D05 PA Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2024-08-15 Capital/Financing Update
Country FR France
Listing PA ALIKO

About Ikonisys S.A.

https://www.ikonisys.com

Ikonisys S.A. is a cell-based diagnostics company specializing in Fluorescence in Situ Hybridization (FISH) technology for genetic analysis. The company develops, manufactures, and markets integrated solutions that include proprietary automated microscopy instruments, advanced software, and reagents. These systems are designed to improve efficiency, accuracy, and standardization for pathologists and laboratory technicians. Ikonisys's technology enables the precise detection and analysis of chromosomal alterations, supporting early and accurate cancer diagnosis, prognosis, and the selection and monitoring of personalized therapies. The platform's automation and digitization features streamline the entire workflow from image acquisition to quantitative interpretation for oncology and genetic testing applications.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 99% confidence The document is a press release titled "Ikonisys a finalisé une augmentation de capital par le biais d'un placement privé" (Ikonisys finalized a capital increase through a private placement). It details the issuance of new shares, the amount raised (150 K€), the price per share, the impact on existing shareholders (dilution), and the resulting capital structure. This content directly relates to fundraising, financing activities, and changes in the capital structure. Based on the definitions: - It is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). - It explicitly discusses an 'augmentation de capital' (capital increase) and 'placement privé' (private placement). - This aligns perfectly with the definition for Capital/Financing Update (Code: CAP): "Updates on company fundraising, financing activities, or capital structure changes." - It is not a general announcement of a report (RPA) or a miscellaneous filing (RNS), as it contains the substantive details of the financing event itself.
2024-08-15 French
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated July 18, 2024, announcing that Ikonisys has completed a capital increase via a private placement ('augmentation de capital par le biais d'un placement privé'). It details the amount raised (250 K€), the investor (CC Holding Srl), the legal framework (approval by the Board, reference to a prior shareholder resolution), the issuance of new shares, and the resulting dilution and capital structure changes. This content directly relates to fundraising, financing activities, and capital structure changes. Based on the definitions: - It is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). - It explicitly details a capital increase and financing, matching the description for 'Capital/Financing Update' (CAP). - It is not a mere announcement of a report (RPA) or a general regulatory filing (RNS), as it contains the substantive details of the transaction itself. Therefore, the most appropriate classification is CAP.
2024-07-18 French
Inside Information / Operations of the issuer (acquisitions, sales...)
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated July 18, 2024, announcing that Ikonisys SA has completed a capital increase of €250k via a private placement. The core subject is the issuance of new shares and the resulting change in capital structure and shareholder percentages. This directly relates to fundraising, financing activities, and capital structure changes. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), as it focuses solely on a financing event.
2024-07-18 English
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release dated July 9, 2024, announcing that Ikonisys's subsidiary, Hospitex International, signed supply contracts in Italy. It details the nature of the contracts (supply of BLOCKfast cytology kits) and includes commentary from the CEOs. This type of announcement, focusing on significant business developments, contract wins, and market positioning, is characteristic of a general corporate announcement or press release. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed quarterly report (IR). Since it is a specific business update that doesn't fit the highly specialized categories (like DIRS, DIV, CAP, etc.), the most appropriate general category for a significant, non-standard corporate announcement that might be filed with regulators or distributed widely is 'Regulatory Filings' (RNS) as a fallback, or potentially an 'Earnings Release' (ER) if it were tied to a specific reporting period, but here it is a standalone business development announcement. Given the options, and since it's a press release announcing business success rather than a formal financial report or a specific event disclosure, RNS (Regulatory Filings/General Announcement) is the best fit as a catch-all for significant, non-standard news releases.
2024-07-09 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release dated July 9, 2024, announcing that Ikonisys' partner, Hospitex International, has signed two 4-year distribution contracts in Italy for diagnostic kits. The text details the business development, the products involved (BLOCKfast), quotes management, and includes standard 'About Us' sections and a forward-looking statement disclaimer. This type of announcement, focusing on significant commercial agreements and business updates outside of mandatory periodic financial reporting (like 10-K or IR), is best classified as a general business update or news release. Since there is no specific category for 'Business Development Announcement' and it is not a formal regulatory filing like a Director's Dealing (DIRS) or Major Shareholding (MRQ), it falls under the general regulatory announcement category, RNS, which serves as a catch-all for significant, non-standard disclosures.
2024-07-09 French
Annual financial and audit reports / Terms of availability of the annual financial report
Report Publication Announcement Classification · 100% confidence The document is a short announcement dated July 8, 2024, stating that the '2023 Annual Financial Report, for the year ended December 31, 2023, is now available and was filed with the Autorité des Marchés Financiers (AMF).' It then directs the reader to the company's investor website to access the document. According to Rule #2 (The 'MENU VS MEAL' Rule), when a document is short and announces the publication of a full report (like an Annual Report), it should be classified as a Report Publication Announcement (RPA), not the report itself (10-K). Although the content relates to the Annual Report (10-K), the document's function is purely to announce its availability.
2024-07-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.